The researchers found 25.6 million people aged 15 to 49 years had new HSV-2 infections and 519.5 million (13.3%) had existing (prevalent) HSV-2 infections globally in 2020. (HealthDay News) — The ...

Unveiling a global crisis: groundbreaking research highlights the immense impact of HSV infections on health, urging a shift towards vaccine innovation and prevention measures. Study: Estimated global ...

– Clinical and preclinical data supporting dosing profile and tolerability for ABI-5366, a novel long-acting helicase-primase inhibitor candidate, featured in two poster presentations – – Additional ...

The World Health Organization (WHO) recently released new estimates suggesting around 846 million people aged between 15 and 49 live with a genital herpes infection. That's equivalent to one in every ...

The present study provides an update on previous estimates of the global and regional incidence (new cases) and prevalence (existing ones) of HSV-1 and HSV-2 in 2012 and 2016. In addition to estimates ...

Fewer Americans aged 14 to 49 years have herpes simplex virus (HSV) types 1 and 2 today than 15 years ago, according to the latest data from the Centers for Disease Control and Prevention's National ...

Herpes is more common than you might think — way more common, actually. In 2020 alone, over 25 million people between the ...

Genital herpes infections are very common. There are 42 million new infections each year — that averages out to one new person infected each second. While treatments can help with symptoms, there's no ...

Objective: The objective of this study was to provide information on the prevalence of herpes simplex infections in the general population in Europe. Goals: The goals of this study were to determine ...

This is a preview. Log in through your library . Abstract Background: Data comparing type-specific herpes simplex virus type 2 (HSV-2) seroprevalence and risk factors between comparable populations ...

Number of people with at least one episode of HSV-attributable genital ulcer disease was 187.9 and 16.7 million for HSV-2, HSV-1 in 2020. (HealthDay News) — The incidence and prevalence of genital ...

– ABI-5366 is currently being evaluated in ongoing Phase 1b clinical trial with interim proof-of-concept data expected in fall 2025 – SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- ...